Meridian and Earth draft a shared longevity dataset — with nine pages missing
Negotiators build a record neither side owns, then agree not to look at everything in it.
Meridian, the largest independent colony, built a longevity industry unbound by Earthside caution and now wants to export its protocols — cheaper, faster, and by Earth's rules, undertested. Earthside regulators say the colony is running a population-scale experiment and marketing the results as therapy. Meridian answers that Earth's 'caution' is really a cartel protecting its own waitlists. Patients are already booking transfer windows to receive treatment where the rules are looser. The dispute pits colonial sovereignty against medical safety, and threatens to make the transfer calendar itself a health policy, as the desperate vote with their tickets.
Negotiators build a record neither side owns, then agree not to look at everything in it.
A sealed fever case tests whether a joint audit can verify safety without opening the colony's books.
Negotiators are sketching shared oversight that would let Earth see longevity protocols it has never examined, and testing how much sovereignty Meridian will spend to keep nine pages closed.
Nine pages about one transient fever have become the whole argument over whether Meridian is running therapy or an experiment it would rather Earth not read.
The colony that never let Earth examine its longevity protocols now offers a limited audit, with the nine pages that started the argument still sealed.
Thirty days without an adverse event strengthens Meridian's case against Earthside caution. It also raises the price of nine sealed pages.
The colony proposes a jointly audited dataset, its first concession after withholding a disputed fever record through three charter sales.
The colony released forty-one pages, redacted nine, refused the full dataset a fourth time, and sold every berth on its next crossing before the ink dried.
Two cohorts came home clean and the third just sold its final berth. The record on one fever still runs nine pages short, and a therapy no regulator has read leaves in sixty-one days.
Whether Earth can regulate a therapy it has never been allowed to examine now comes down to one patient record, and the colony still won't hand over nine of its pages.
No repeat of the sealed fever, and Earth's refusal to examine the protocols now looks less like caution and more like a course held out of habit.
The colony released a redacted account of the first cohort's fever case, and Earth's board says the missing pages are the ones that would let it regulate at all.
After a transfer window that closed with the fever file still sealed, forty-one arriving patients cleared their first screening — and the whole quarrel now hangs on whether they stay well.
Two regulators seal one patient's record from opposite ends, and a second cohort has already bought its tickets.
The desperate are voting with charter tickets, and the manifest for the next voyage now carries more berths than the first — before anyone has agreed whether the therapy is safe or merely unproven.
Two authorities cite two different reasons for the same silence, and a second cohort books passage into the gap between them.
Earth's regulators won't certify the colony's longevity protocols, yet won't bar their own citizens from sailing for them. The manifest is already full.
Whether Earth can bar its citizens from off-world treatment now rides on a single returning fever.
Whether Earth can bar its citizens from Meridian's protocols hinges on a single adverse case neither regulator fully owns, and the next charter is already booked.
A charter ticket to Meridian is becoming a prescription, and Earthside caution over untested longevity has no way to reach across the transfer window.